Subscribe

Stay Informed. Stay Ahead.

Subscribe to receive curated updates, expert insights, and practical education—delivered straight to your inbox.

Get timely coverage on new approvals, case-based discussions, conference highlights, and practical tools for everyday practice in community oncology and hematology.

Subscribe
*
Skip to main content
OncUpdates
  • Conferences
    • ASCO GU
    • ASCO GI
    • ASH
    • SABCS
    • ESMO
    • WCLC
    • ASCO
  • Videos & Podcasts
    • Challenging Cases
      • Hematology
      • Lung Cancer
      • Breast Cancer
      • GU Oncology
    • New Approvals
      • Hematology
      • GI Oncology
      • GU Oncology
      • Lung Cancer
      • Breast Cancer
    • Tox Check
      • GI Oncology
      • GU Oncology
      • Lung Cancer
      • Breast Cancer
      • Hematology
    • Treatment Algorithms
      • Breast Cancer
      • Dermatology
      • Hematology
      • Lung Cancer
      • Ovarian Cancer
      • Head and Neck Cancers
  • Clinical Insights
    • GU Oncology
      • Bladder Cancer
      • RCC
    • GI Oncology
      • Gastroesophageal Cancer
      • Gastric/GEJ Cancer
    • Breast Cancer
      • Early HR+
      • Metastatic HR+
    • Hematology
      • Polycythemia Vera
    • Lung Cancer
      • SCLC
      • NSCLC
  • Resource Centers
    • Pancreatic Cancer
    • Metastatic Breast Cancer
  • Articles
    • GI Oncology
    • Hematology
    • Lung Cancer
  • Events
  • Conferences
    • ASCO GU
    • ASCO GI
    • ASH
    • SABCS
    • ESMO
    • WCLC
    • ASCO
  • Videos & Podcasts
    • Challenging Cases
      • Hematology
      • Lung Cancer
      • Breast Cancer
      • GU Oncology
    • New Approvals
      • Hematology
      • GI Oncology
      • GU Oncology
      • Lung Cancer
      • Breast Cancer
    • Tox Check
      • GI Oncology
      • GU Oncology
      • Lung Cancer
      • Breast Cancer
      • Hematology
    • Treatment Algorithms
      • Breast Cancer
      • Dermatology
      • Hematology
      • Lung Cancer
      • Ovarian Cancer
      • Head and Neck Cancers
  • Clinical Insights
    • GU Oncology
      • Bladder Cancer
      • RCC
    • GI Oncology
      • Gastroesophageal Cancer
      • Gastric/GEJ Cancer
    • Breast Cancer
      • Early HR+
      • Metastatic HR+
    • Hematology
      • Polycythemia Vera
    • Lung Cancer
      • SCLC
      • NSCLC
  • Resource Centers
    • Pancreatic Cancer
    • Metastatic Breast Cancer
  • Articles
    • GI Oncology
    • Hematology
    • Lung Cancer
  • Events

Explore Videos, Articles & More

Prostate Cancer

Clinical data, expert insights, and treatment advancements presented at the ASCO Genitourinary Cancers Symposium prostate cancer sessions, focusing on practice-informing updates.

Home / Conferences / ASCO GU / Prostate Cancer
Community Takeaways From ASCO GU 2026
Community Takeaways From ASCO GU 2026

Regina Barragan-Carrillo, MD, Raji Shameem, MD

ASCO GU 2026: Experts Highlight Key Updates in Prostate Cancer
ASCO GU 2026: Experts Highlight Key Updates in Prostate Cancer

Brooke Kania, DO, Sindhuja Kadambi, MD, MS

A Personalized Approach to Treating GU Cancers
A Personalized Approach to Treating GU Cancers

Sophia Kamran, MD, Natalie Reizine, MD

PEACE-3 OS Data Support Radium-223 Plus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
PEACE-3 OS Data Support Radium-223 Plus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer

Sindhuja Kadambi, MD, MS, Karine Tawagi, MD

PARP Inhibitor Combination Therapy in Metastatic Prostate Cancer
PARP Inhibitor Combination Therapy in Metastatic Prostate Cancer

Karan Jatwani, MD, Jeffrey Zhong, MD

Capivasertib Plus Abiraterone in Metastatic Prostate Cancer
Capivasertib Plus Abiraterone in Metastatic Prostate Cancer

Alan Bryce, MD, Karan Jatwani, MD

OncUpdates

Empowering oncology professionals with The latest insights, breakthroughs, And expert opinions

Quick Links

  • About Us
  • Upcoming Events
  • Follow on X
  • Follow on LinkedIn
  • Follow on YouTube

Legal

  • Terms of Use
  • Privacy Policy
  • Cookie Settings
  • Authors
  • Contact Us

Subscribe to Our Newsletters


Property of SignifyMD LLC, All Rights Reserved 2026 SignifyMD LLC PO Box 512, Brielle, NJ 08730


Oncology Resources | Hematology Support | Community Oncology